Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
Public ClinicalTrials.gov record NCT07511361. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Two-Part Study to Evaluate the Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the blood pressure-lowering effect of tonlamarsen in adult participants who were recently hospitalized and concurrently experienced an episode of acute severe hypertension.
Study identification
- NCT ID
- NCT07511361
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 140 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 22, 2026
- Primary completion
- Nov 30, 2026
- Completion
- Jan 31, 2027
- Last update posted
- Sep 1, 2026
2026 – 2027
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Western Nephrology and Metabolic Bone Disease, PC - Arvada | Arvada | Colorado | 80002 | Recruiting |
| Homestead Associates in Research | Homestead | Florida | 33033 | Recruiting |
| Progressive Medical Research | Port Orange | Florida | 32127 | Recruiting |
| Eagle Clinical Research | Chicago | Illinois | 60621 | Recruiting |
| Richmond University Medical Center (RUMC) | Staten Island | New York | 10310 | Recruiting |
| Research Innovations, LLC | Beavercreek | Ohio | 05431 | Recruiting |
| OnSite Clinical Solutions, LLC | Fort Mill | South Carolina | 29715 | Recruiting |
| Chattanooga Research & Medicine CHARM | Chattanooga | Tennessee | 37404 | Recruiting |
| Laguna Clinical Research Associates | Laredo | Texas | 78041 | Recruiting |
| Tapia Internal Medicine Clinic | Paris | Texas | 75460 | Recruiting |
| Baylor Scott and White Research Institute - Temple | Temple | Texas | 76502 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07511361, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 1, 2026 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07511361 live on ClinicalTrials.gov.